Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


14.05.2018

1 Ann Neurol
1 Ann Nucl Med
1 Appl Radiat Isot
2 Brain
14 Clin Nucl Med
1 Curr Opin Cardiol
2 IEEE Trans Med Imaging
1 J Neuroimaging
8 J Nucl Med
1 Nucl Med Commun
2 Phys Med Biol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. ALSHIKHO MJ, Zurcher NR, Loggia ML, Cernasov P, et al
    Integrated MRI and [(11) C]-PBR28 PET Imaging in Amyotrophic Lateral sclerosis.
    Ann Neurol. 2018 May 8. doi: 10.1002/ana.25251.
    PubMed     Text format     Abstract available


    Ann Nucl Med

  2. SAUERBECK J, Ishii K, Hosokawa C, Kaida H, et al
    The correlation between striatal and cortical binding ratio of (11)C-PiB-PET in amyloid-uptake-positive patients.
    Ann Nucl Med. 2018 May 5. pii: 10.1007/s12149-018-1258.
    PubMed     Text format     Abstract available


    Appl Radiat Isot

  3. CHAKRABORTY S, Vimalnath KV, Chakravarty R, Sarma HD, et al
    Multidose formulation of ready-to-use (177)Lu-PSMA-617 in a centralized radiopharmacy set-up.
    Appl Radiat Isot. 2018;139:91-97.
    PubMed     Text format     Abstract available


    Brain

  4. SMITH CB, Schmidt KC
    Measurement of regional rates of protein synthesis in human brain in vivo with L-[1-11C]-leucine PET.
    Brain. 2018 May 3. pii: 4992170. doi: 10.1093.
    PubMed     Text format    

  5. SMEETS JSJ, van Loon LJC
    Reply: Measurement of regional rates of protein synthesis in human brain in vivo with L-[1-11C]-leucine PET.
    Brain. 2018 May 3. pii: 4992171. doi: 10.1093.
    PubMed     Text format    


    Clin Nucl Med

  6. HOU G, Li X, Hou B, Zhou W, et al
    Lymphangioma on 68Ga-NOTA-Evans Blue PET/MRI.
    Clin Nucl Med. 2018 May 7. doi: 10.1097/RLU.0000000000002129.
    PubMed     Text format     Abstract available

  7. LUO Y, Pan Q, Feng J, Cao X, et al
    Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenstrom Macroglobulinemia.
    Clin Nucl Med. 2018 May 7. doi: 10.1097/RLU.0000000000002131.
    PubMed     Text format     Abstract available

  8. ACHONG DM
    Clinical Significance of a Solitary Cold Thyroid Nodule in the Setting of Graves Disease.
    Clin Nucl Med. 2017 Nov 17. doi: 10.1097/RLU.0000000000001897.
    PubMed     Text format     Abstract available

  9. CALANDRIELLO L, Larici AR, Leccisotti L, Del Ciello A, et al
    Multifunctional Assessment of Non-Small Cell Lung Cancer: Perfusion-Metabolic Correlation.
    Clin Nucl Med. 2017 Nov 17. doi: 10.1097/RLU.0000000000001888.
    PubMed     Text format     Abstract available

  10. TINAZ S, Chow C, Kuo PH, Krupinski EA, et al
    Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease.
    Clin Nucl Med. 2018;43:e1-e7.
    PubMed     Text format     Abstract available

  11. ZHOU H, Yan J, Huang R, Li L, et al
    Unusual Uptake of 131I in a Cutaneous Benign Fibrous Histiocytoma in a Patient With Thyroid Cancer.
    Clin Nucl Med. 2017 Oct 26. doi: 10.1097/RLU.0000000000001865.
    PubMed     Text format     Abstract available

  12. BAI X, Wang X
    Solitary Breast Metastasis From Rhabdomyosarcoma Shown on FDG PET/CT.
    Clin Nucl Med. 2018 May 7. doi: 10.1097/RLU.0000000000002125.
    PubMed     Text format     Abstract available

  13. LUO Y, Wang L, Pan Q, Ma Y, et al
    Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC.
    Clin Nucl Med. 2018 May 7. doi: 10.1097/RLU.0000000000002124.
    PubMed     Text format     Abstract available

  14. AL-ZAGHAL A, Werner TJ, Hoilund-Carlsen PF, Alavi A, et al
    The Detection of Uterine Leiomyoma (Fibroid) Calcifications on 18F-NaF PET/CT.
    Clin Nucl Med. 2018 May 7. doi: 10.1097/RLU.0000000000002122.
    PubMed     Text format     Abstract available

  15. VARGHESE B, Velez E, Desai B, Jadvar H, et al
    Incidental Detection of Meningioma by 18F-FMAU PET/CT in a Patient With Suspected Prostate Cancer.
    Clin Nucl Med. 2018 May 7. doi: 10.1097/RLU.0000000000002123.
    PubMed     Text format     Abstract available

  16. UNTERRAINER M, Fleischmann DF, Lindner S, Brendel M, et al
    Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180.
    Clin Nucl Med. 2018 Apr 30. doi: 10.1097/RLU.0000000000002113.
    PubMed     Text format     Abstract available

  17. SNOW HA, Hofman MS, Mitchell CA, Gyorki DE, et al
    Incidental Metastatic Melanoma Identified on 68Ga-Prostate-Specific Membrane Antigen PET/CT for Metastatic Prostate Cancer.
    Clin Nucl Med. 2018 Apr 30. doi: 10.1097/RLU.0000000000002111.
    PubMed     Text format     Abstract available

  18. MOUBTAKIR A, Dejust S, Godard F, Messaoud L, et al
    18F-FDG PET/CT in Anti-NMDA Receptor Encephalitis: Typical Pattern and Follow-up.
    Clin Nucl Med. 2018 Apr 30. doi: 10.1097/RLU.0000000000002098.
    PubMed     Text format     Abstract available

  19. GROSSE HOKAMP N, Kobe C, O'Donnell JK, Gupta A, et al
    Falciform Ligament Artery Uptake on 99mTc MAA Planning Scan Before 90Y SIRT Confirmed by Retrospective SPECT/MRI Fusion.
    Clin Nucl Med. 2018 Apr 30. doi: 10.1097/RLU.0000000000002099.
    PubMed     Text format     Abstract available


    Curr Opin Cardiol

  20. TAQUETI VR, Di Carli MF
    Clinical significance of noninvasive coronary flow reserve assessment in patients with ischemic heart disease.
    Curr Opin Cardiol. 2016.
    PubMed     Text format     Abstract available


    IEEE Trans Med Imaging

  21. FENG T, Wang J, Sun Y, Zhu W, et al
    Self-Gating: An Adaptive Center-of-Mass Approach for Respiratory Gating in PET.
    IEEE Trans Med Imaging. 2018;37:1140-1148.
    PubMed     Text format     Abstract available

  22. MOU T, Huang J, O'Sullivan F
    The Gamma Characteristic of Reconstructed PET Images: Implications for ROI Analysis.
    IEEE Trans Med Imaging. 2018;37:1092-1102.
    PubMed     Text format     Abstract available


    J Neuroimaging

  23. KANG Y, Mozley PD, Verma A, Schlyer D, et al
    Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease.
    J Neuroimaging. 2018 May 4. doi: 10.1111/jon.12519.
    PubMed     Text format     Abstract available


    J Nucl Med

  24. WEIST MR, Starr R, Aguilar B, Chea J, et al
    Positron emission tomography of adoptively transferred chimeric antigen receptor T cells with Zirconium-89 oxine.
    J Nucl Med. 2018 May 4. pii: jnumed.117.206714. doi: 10.2967/jnumed.117.206714.
    PubMed     Text format     Abstract available

  25. BURGGRAAFF CN, Cornelisse AC, Hoekstra OS, Lugtenburg PJ, et al
    Interobserver agreement of interim and end-of-treatment (18)F-FDG PET/CT in diffuse large B-cell lymphoma (DLBCL): impact on clinical practice and trials.
    J Nucl Med. 2018 May 4. pii: jnumed.118.210807. doi: 10.2967/jnumed.118.210807.
    PubMed     Text format     Abstract available

  26. ELSCHOT M, Selnaes KM, Johansen H, Kruger-Stokke B, et al
    The Effect of Including Bone in DIXON-based Attenuation Correction for (18)F-fluciclovine PET/MRI of Prostate Cancer.
    J Nucl Med. 2018 May 4. pii: jnumed.118.208868. doi: 10.2967/jnumed.118.208868.
    PubMed     Text format     Abstract available

  27. DOUGHTON JA, Hofman MS, Eu P, Hicks RJ, et al
    A first-in-man study of (68)Ga-nanocolloid PET-CT sentinel lymph node imaging in prostate cancer demonstrates aberrant lymphatic drainage pathways.
    J Nucl Med. 2018 May 4. pii: jnumed.118.209171. doi: 10.2967/jnumed.118.209171.
    PubMed     Text format     Abstract available

  28. WONG DF, Comley R, Kuwabara H, Rosenberg PB, et al
    First in-human PET study of 3 novel tau radiopharmaceuticals: [(11)C]RO6924963, [(11)C]RO6931643, and [(18)F]RO6958948.
    J Nucl Med. 2018 May 4. pii: jnumed.118.209916. doi: 10.2967/jnumed.118.209916.
    PubMed     Text format     Abstract available

  29. PETERSON LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, et al
    Prospective study of serial (18)F-FDG PET and (18)F-fluoride ((18)F-NaF) PET to predict time to skeletal related events, time-to-progression, and survival in patients with bone-dominant metastatic breast cancer.
    J Nucl Med. 2018 May 10. pii: jnumed.118.211102. doi: 10.2967/jnumed.118.211102.
    PubMed     Text format     Abstract available

  30. AUVITY S, Caille F, Marie S, Wimberley C, et al
    P-glycoprotein (ABCB1) inhibits the influx and increases the efflux of (11)C-metoclopramide across the blood-brain barrier: a PET study on non-human primates.
    J Nucl Med. 2018 May 10. pii: jnumed.118.210104. doi: 10.2967/jnumed.118.210104.
    PubMed     Text format     Abstract available

  31. BRANDT M, Cardinale J, Aulsebrook M, Gasser G, et al
    AN OVERVIEW ON PET RADIOCHEMISTRY: PART 2 - RADIOMETALS.
    J Nucl Med. 2018 May 10. pii: jnumed.117.190801. doi: 10.2967/jnumed.117.190801.
    PubMed     Text format     Abstract available


    Nucl Med Commun

  32. LU Z, Xie J, Yan R, Yu Z, et al
    A pilot study of pancreatic islet amyloid PET imaging with [18F]FDDNP.
    Nucl Med Commun. 2018 May 5. doi: 10.1097/MNM.0000000000000849.
    PubMed     Text format     Abstract available


    Phys Med Biol

  33. ARINO-ESTRADA G, Du J, Kim H, Cirignano LJ, et al
    Development of TlBr detectors for PET imaging.
    Phys Med Biol. 2018 May 4. doi: 10.1088/1361-6560.
    PubMed     Text format     Abstract available

  34. NAMIAS M, Bradshaw T, Menezes VO, Machado MAD, et al
    A novel approach for quantitative harmonization in PET.
    Phys Med Biol. 2018;63:095019.
    PubMed     Text format     Abstract available


    PLoS One

  35. PARK SB, Park JM, Moon SH, Cho YS, et al
    Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis.
    PLoS One. 2018;13:e0196808.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: